IFNA2 and panuveitis: It has been shown that plasmacytoid DCs obtained from patients with refractory panuveitis including BU showed reduced capacity to produce IFN-α after stimulation, which implies that IFN-α therapy could augment the defective function of plasmacytoid DCs in these patients [169].